Denali Advisors sells stake in Exactech: 5 notes

During the fourth quarter, Denali Advisors sold its stake in Exactech, according to EMQ News & Analysis.

Advertisement

Here are five notes:

 

1. Denali Advisors previously held 100 shares in Exactech, for a total value of $1,862.

 

2. On Jan. 28, Exactech shares reached $18.62, up nearly 1.1 percent.

 

3. The company’s 50-day moving average is $18.22 and 200-day moving average is $18.41.

 

4. The market cap is $262.13 million and P/E ratio is 16.64.

 

5. Exactech has a one-year high of $26.20 and one-year low of $16.11. 

 

More article on devices:
Loma Linda University health clinic 1st in state to implant St. Jude Medical Invisible Trial System: 4 things to know
Global orthopedic trauma devices market to reach $9.4B by 2020: 5 key trends
Global orthopedic trauma devices market to reach $9.4B by 2020: 5 key trends

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.